Next Article in Journal
Retinitis Pigmentosa: Progress in Molecular Pathology and Biotherapeutical Strategies
Previous Article in Journal
Comparison of BMIPP-SPECT/CT to 18FDG-PET/CT for Imaging Brown or Browning Fat in a Preclinical Model
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 23
Issue 9
10.3390/ijms23094882
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Neurogenesis of Subventricular Zone Progenitors in the Premature Cortex of Ferrets Facilitated by Neonatal Valproic Acid Exposure

by
Kazuhiko Sawada
Department of Nutrition, Faculty of Medical and Health Sciences, Tsukuba International University, Tsuchiura 300-0051, Ibaraki, Japan
Int. J. Mol. Sci. 2022, 23(9), 4882; https://doi.org/10.3390/ijms23094882
Submission received: 25 March 2022 / Revised: 19 April 2022 / Accepted: 20 April 2022 / Published: 28 April 2022
(This article belongs to the Section Molecular Neurobiology)
Browse Figures
Versions Notes

Abstract

:
The present study evaluated the neurogenesis of neonatal valproic acid (VPA) exposure on subventricular zone progenitors of the developing cerebral cortex in ferrets. VPA was injected at a dose of 200 µg/g of body weight into ferret infants on postnatal days 6 and 7. Two different thymidine analogues, 5-ethynyl-2′-deoxyuridine (EdU) and 5-bromo-2′-deoxyuridine (BrdU), were injected with a 48 h interval to label proliferating cells before and after VPA exposure. Two hours after BrdU injection, BrdU single- and EdU/BrdU double-labeled cells, but not EdU single-labeled cells, were significantly denser in both the inner and outer subventricular zones of VPA-exposed infants than in control infants. Notably, more than 97% of BrdU single- and EdU/BrdU double-labeled cells were immunopositive for Pax6, a stable marker for basal radial glia (bRG), in both groups. In contrast, the percentage of cells positively immunostained for Cux1, a postmitotic marker for upper-layer cortical neurons, in both EdU single- and BrdU single-labeled cells, was significantly higher in VPA-exposed infants than in control infants. These findings suggest that neonatal VPA exposure facilitates bRG proliferation, including self-renewal, followed by their differentiation into upper layer cortical neurons in the premature cortex of ferrets.

1. Introduction

Valproic acid (VPA), an antiepileptic/anticonvulsant drug, is also known to be an inhibitor of histone deacetylases 1 and 2 [1]. When various mammalian species [2,3,4,5,6,7,8], including ferrets [9], are exposed to VPA during prenatal and early postnatal development, it may cause social behaviors associated with autism spectrum disorder (ASD). Altered brain morphology due to developmental VPA exposure has been reported mainly in the cerebral cortex, and includes cortical thickening [10,11] or thinning [4], an increased number of cortical neurons [7] and altered gyrification [12,13,14,15]. Our recent study revealed altered sulcal infolding with an increased neuron density and cortical thickening in the sulcal floors following neonatal VPA exposure in a gyrencephalic animal model, the ferret [16]. Some human ASD patients reportedly exhibit similar cortical characteristics [17,18,19].
VPA mediates neurogenesis by regulating the proliferation, maintenance, and differentiation of neuronal stem/progenitor cells, although the effects of VPA vary depending on the exposure time points and neuronal stem/progenitor cell types. For example, VPA mediates the upregulation of Wnt/β-catenin pathways [20] and the proliferation of dentate gyrus (DG) progenitors in the developing hippocampus [21,22], and promotes the adult neurogenesis of DG progenitors by inhibiting HDAC activity [23]. In contrast, VPA alters the cell-cycle exit of subventricular zone (SVZ) progenitors via the inhibition of HDAC activity during the early stage of cortical neurogenesis in mice [11]. In our recent study, VPA exposure during the late stage of cortical neurogenesis increased the density of cortical neurons derived from basal radial glia (bRG) in ferrets [16]. The bRG, also called the outer RG or transient RG, are self-renewable neuronal stem cells that appear transiently in the inner and outer subventricular zones (iSVZ and oSVZ) during cortical neurogenesis in humans [24,25] and other mammalian species [26,27,28,29], including ferrets [30]. They are distinct from intermediate progenitor cells which are classically known cortical progenitors [24,25]. Likewise, bRG emerges in the developing cortex of mice, but is less abundant than in primates and carnivores [26,27]. Therefore, ferrets are more suitable than rodents for investigating the effect of VPA with bRG as a target. Therefore, this study aimed to determine the intermediate influence of VPA exposure on the proliferation, maintenance, and/or differentiation of bRG in the developing cerebral cortex, which may be involved in gyrification anomalies previously reported in ferrets [16]. Two thymidine analogues, 5-ethynyl-2′-deoxyuridine (EdU) and 5-bromo-2′-deoxyuridine (BrdU), were administered within a 48 h interval to label proliferating cells before and after VPA exposure. This administration schedule can also label self-renewing bRG in ferrets [30].

2. Results

2.1. Immunofluorescence Staining for Various Markers with EdU and BrdU Labeling

EdU-labeled cells, which proliferated 24 h before the first VPA injection (at postnatal day (PD) 5), were distributed abundantly in the iSVZ and diffusely in the oSVZ on PD 7 (Figure 1a). Although a great majority of these cells were single-labeled with EdU, some were also labeled with BrdU, indicating that these cells experienced a second round of cell division 48 h after EdU injection in both VPA-exposed and control groups (Figure 1). In contrast, BrdU single-labeled cells were distributed diffusely in the iSVZ through the oSVZ (Figure 1a). BrdU labeling was observed in proliferating cells immediately following the second VPA injection in the VPA-exposed group. Positivity of immunostaining for various markers was examined in EdU single-, BrdU single-, and EdU/BrdU double-labeled cells. Some of these cells were immunopositive for Sox2 (a marker for neuronal stem cells [28,29,31]) (Figure 1); Pax6 (a stable marker for bRG across mammals [28,29,31]) (Figure 2); Olig2 (expressed in progenitors with glial progeny [29,31]) (Figure 3); Cux1 (a marker for postmitotic upper cortical layer neurons [32]) (Figure 4a); and Ctip2 (a marker for postmitotic upper cortical layer neurons [33]) (Figure 4b).

2.2. Densities of EdU Single-, BrdU Single- and EdU/BrdU Double-Labeled Cells

The present study was designed to label proliferating cells with EdU 24 h prior to VPA injection (PD 5) and with BrdU immediately following two consecutive days of VPA injection (PD 7). The 48 h interval between EdU and BrdU administration would lead to the labeling of self-renewing bRG in the ferret premature cortex because it covers the minimum time for the S-shape of either the first or second round of cell divisions [30]. No statistical difference in the density of EdU single-labeled cells between VPA-exposed and control ferret infants was observed for either the iSVZ or oSVZ, indicating no alteration in cell proliferation (Figure 5). In contrast, a significant main effect at the group level was detected in the density of BrdU single-labeled cells by two-way repeated-measures ANOVA (F(1,4) = 150.928; p < 0.001). Scheffe’s test indicated significantly denser BrdU single-labeled cells in both the iSVZ (p < 0.001) and oSVZ (p < 0.001) in VPA-exposed infants than in control infants (Figure 5). Notably, although a small population of proliferating cells on PD 5 experienced self-renewal after a 48 h interval (EdU/BrdU double-labeled cells), they were significantly denser in VPA-exposed infants than in control infants and were detected either in the iSVZ (p < 0.01) or oSVZ (p < 0.01) (Scheffe’s test), following a significant main effect on the group by two-way repeated-measures ANOVA (F(1,4) = 20.196; p < 0.05) (Figure 5).

2.3. Incidence of Immunostaining for Various Markers in EdU Single-, BrdU Single- and EdU/BrdU Double-Labeled Cells

The incidence of cells immunostained for various markers was estimated in EdU single-, BrdU single-, and EdU/BrdU double-labeled cells in the SVZ, and the results are shown in Table 1. Incidence was estimated independently for each marker antigen. Therefore, the proportion at which the expression of each antigen overlapped with one another is unclear.
In both VPA-exposed and control infants, EdU single-labeled cells were immunopositive for Sox2, Cux1, and Ctip2 in a small population of less than 10% of cells for each marker. Significantly greater incidences of Sox2 (p < 0.01) and Cux1 (p < 0.01) expression in EdU single-labeled cells were observed in VPA-exposed infants than in control infants (Table 1). Pax6 immunostaining was observed in EdU single-labeled cells at a relatively larger proportion compared with other markers. Pax6 immunostaining was observed in 32.0% of EdU single-labeled cells in control infants, which was significantly reduced to 24.5% in VPA-exposed infants (p < 0.05) (Table 1). In contrast, a significant difference in the incidence of Olig2 immunostaining was observed: 14.3% of EdU single-labeled cells in control infants and 6.9% in VPA-exposed infants (p < 0.001) (Table 1).
More than 80% of BrdU single-labeled cells were immunopositive for the neuronal stem/progenitor cell markers Sox2 and Pax6 in both groups (Table 1). A significantly greater incidence of immunostaining for Pax6, but not Sox2, was detected in the VPA-exposed infants than in the control infants (p < 0.05) (Table 1). Cux1 immunostaining was observed in 24.4% of BrdU single-labeled cells in control infants, and a significant increase (p < 0.05) in 34.8% of such cells in VPA-exposed infants (Table 1). There were no differences in the incidence of Olig2 and Ctip2 expression between the two groups (Table 1).
Among EdU/BrdU double-labeled cells, the incidence of Pax6 immunostaining was significantly higher in VPA-exposed infants (98.5%) than in control infants (82.0%) (p < 0.05) (Table 1). However, the incidence of Sox2 immunostaining was significantly lower in VPA-exposed infants (86.1%) than in control infants (100%) (p < 0.05) (Table 1).

3. Discussion

VPA is known to mediate neurogenesis by regulating the proliferation, maintenance, and/or differentiation of neuronal stem/progenitor cells, although VPA exhibits diverse effects depending on the type of neuronal stem/progenitor cells and the developmental stages of the brain [11,20,21,22,23,34,35]. In the current study, more than 90% of BrdU single-labeled cells in the SVZ were immunopositive for Pax6, which is a stable marker for bRG across mammals [28,29,31], and their density increased immediately following VPA exposure in PD 7 ferrets. Such VPA-related changes may not be accompanied by a massive loss of SVZ progenitors, because VPA prevented apoptosis [36] and increased the anti-apoptotic factors (such as Bcl-2) of neuronal progenitors [37,38]. The present study further examined the effect of VPA on SVZ progenitors that had already experienced the S-phase before VPA exposure (on PD 5) using EdU labeling. A large population of proliferating SVZ progenitors on PD 5 was EdU single-labeled, and the density of these cells was not altered by VPA exposure. On the other hand, a small population of proliferating SVZ progenitors on PD 5 was EdU/BrdU double-labeled, and 82.0% of them were Pax6 immunopositive in control infants. Notably, VPA exposure increased EdU/BrdU double-labeled cell density and the incidence of Pax6 immunostaining (98.5%) on PD 7. The 48 h interval between EdU and BrdU administrations applied in the present study covered the minimum times for the S-shape of either the first or second round of bRG cell divisions, allowing self-renewing bRG to be labeled in the ferret premature cortex [30]. Thus, VPA may primarily facilitate SVZ progenitor proliferation, including the self-renewal of bRG, in the ferret premature cortex during the late stage of cortical neurogenesis.
VPA exposure to mice throughout gestation primarily increased the number of Cux1-immunopositive upper cortical-layer neurons and enhanced the non-specific expression of G1-phase regulatory proteins, namely a differentiation-inducing protein p27Kip1, and the differentiation-inhibitory proteins cdk2, cdk4, and cyclinD1 [11]. Juliandi et al. (2012) [34] also reported that Cux1-immunopositive upper layer cortical neurons were induced in vitro from mouse embryonic stem cells by VPA. In the current study, the percentages of cells immunopositive for various markers in SVZ progenitors were significantly altered in ferret infants, although such changes were small. Notably, the incidence of Cux1 immunostaining increased in SVZ progenitors with EdU single and BrdU single labeling immediately after the second VPA injection. These results suggest that VPA exposure at the late stage of cortical neurogenesis also facilitates the differentiation of SVZ progenitors, including bRG, into upper layer cortical neurons in the premature cortex of ferrets. This VPA effect may be mediated by the non-specific enhanced expression of G1-phase regulatory proteins, as observed in mice [11]. Furthermore, the effect of VPA exposure on SVZ progenitors differed before and after S-phase. The expression ratios of various markers in EdU single-labeled cells revealed that SVZ progenitors exposed to VPA after undergoing the S-phase prevented the differentiation into Olig2-positive glial cells and sustained Sox2-positive stem cell characteristics (rather than Pax6-positive bRG characteristics).
Neonatal exposure to VPA, which covers the late stage of cortical neurogenesis, induces ASD-like social behavioral deficits in ferrets [9]. Our recent study revealed a gyrification abnormality with increased neuron density and cortical thickening in the sulcal floors following neonatal VPA exposure in ferrets [16]. In the current investigation, bRG proliferation (including self-renewal), followed by Cux1 immunostaining, was facilitated immediately following VPA exposure in the premature cortex of ferrets. The findings, therefore, suggest that the neurogenesis of upper-layer cortical neurons from bRG is substantial as VPA effects cause gyrification abnormalities seen in VPA-exposed ferrets.

4. Materials and Methods

4.1. Animals

Six male ferrets were purchased on PD 5 from Japan SLC (Hamamatsu, Japan). They were reared with lactating ferret dams (3 pups/mother) in stainless-steel cages (80 cm × 50 cm × 35 cm) kept at 21.5 °C ± 2.5 °C under 12 h artificial illumination in the Facility of Animal Breeding, Nakaizu Laboratory, Japan SLC. All dams were fed a pellet diet (High Density Ferret Diet 5L14, PMI Feeds, Inc., St. Louis, MO, USA) and provided tap water ad libitum.
All ferret infants were injected intraperitoneally with EdU at 30 µg/g body weight (Sigma-Aldrich, St. Louis, MO, USA) on PD 5 and BrdU at 30 µg/g body weight (Sigma-Aldrich) on PD 7. Three infants were administered VPA intraperitoneally at 200 µg/g body weight on PD 6 and 7, corresponding to the late stage of cortical neurogenesis [31]. The schedule for VPA administration was designed in accordance with our recent study [16]. The second injection of VPA was administered at the same time as the BrdU injection. The remaining three infants that did not receive VPA were used as controls. Two hours after BrdU injection, all infants were perfused with 4% paraformaldehyde (PFA) in PBS under deep anesthesia with ~2% isoflurane gas.

4.2. Immunofluorescence Procedures

The cerebral hemispheres were separated on the left and right sides of the longitudinal cerebral fissure, immersed in 30% sucrose in PBS, and embedded in an optimal cutting-temperature compound. Coronal sections were made at 100 μm thickness using a Retratome (REM-700, Yamato Koki Industrial Co., Ltd., Asaka, Japan) with a refrigeration unit (Electro Freeze MC-802A, Yamato Koki Industrial). The brain tissue of infant ferrets is very soft due to unmyelination and a high water content. To maintain the integrity and morphology of the premature cortex, it was necessary to make cryosections of 100 μm thickness. All sections were collected in vials containing a 4% PFA solution.
Five serial coronal sections taken at the level of the anterior commissure underwent immunofluorescence staining and EdU detection. These sections included large expansions of both the iSVZ and oSVZ, and the cortical region examined corresponded to the primary somatosensory cortex [39]. All procedures were performed on floating sections, according to a previous report [30]. Sections were heated in Antigen Retrieval Reagent UNIVERSAL (R&D system, Minneapolis, MN, USA) for 30 min in a 90 °C water bath and then cooled at 4 °C for 30 min. Two hours following a preincubation with PBS containing 0.1% Triton-X 100 (Triton-PBS) at room temperature at 37 °C, EdU was detected on the sections by a reaction with a Click-iT reaction cocktail containing Alexa Fluor 488 (Click-iT EdU Alexa Fluor 488 Imaging Kit, Thermo Fisher Scientific, Waltham, MA, USA) at 37 °C for 2 h. Then, sections were incubated with a mixture of a rat BrdU monoclonal antibody (1:1000; ab6326, Abcam, Cambridge, UK), a goat Sox2 polyclonal antibody (1:500; AF2018, R&D Systems, Minneapolis, MN, USA), mouse Pax6 monoclonal antibody (1:500, ab78545, Abcam, Cambridge, UK), mouse Cux1 monoclonal antibody (1:500, SC-514008, Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), rat Ctip2 monoclonal antibody (1:500, ab18465, Abcam), or rabbit Olig2 polyclonal antibody (1:500; IBL, Gunma, Japan) dissolved in Triton-PBS containing 10% normal horse serum (Vector Labs. Inc. Burlingame, CA, USA) at 4 °C overnight. Highly specific immunostaining was reported in the ferret brain tissue using these primary antibodies [30,40,41]. The sections were subsequently incubated at 37 °C for 2 h with appropriate secondary antibodies, which included Alexa 350 goat anti-rat IgG (1:500; A-21093; Thermo Fisher Scientific, Waltham, MA, USA), Alexa 350 donkey anti-sheep IgG (1:500; A21097, Abcam), Alexa 647 chicken anti-rat IgG (1:500; A-21472, Thermo Fisher Scientific), biotinylated horse anti-mouse IgG (1:200; BA-2001, Vector Labs), and biotinylated donkey anti-rabbit IgG (1:200; A16027, Thermo Fisher Scientific). When using biotinylated secondary antibodies, sections were further incubated with Alexa 555-conjugated streptavidin (1:500, S21381, Thermo Fisher Scientific) at 37 °C for 1 h.

4.3. Evaluating the Density of Immunostained and/or Thymidine Analogue-Labeled Cells

Serial digital sectioning images were acquired at a 10 μm depth (section plane thickness = 1 μm; number of sections = 10) from the most superficial plane, where EdU and BrdU labeling with immunostaining for various markers were obtained. Images were captured with a 20x objective using an Axio Imager M2 ApoTome.2 microscope with a 20× objective equipped with an AxioCam MRm camera (Zeiss, Gottingen, Germany) with Zen 2.3 blue edition software (Zeiss). A set of sectional images, 4 μm apart in the Z-direction (the third and seventh from the superficial slices of the acquired images), were selected as the lookup and reference images, respectively. The disector method using systematic random sampling was used to estimate the density of immunostained and EdU- and/or BrdU-labeled cells according to a previous report [30]. In sections immunostained for each marker, frames with 12 square boxes (box size = 40 × 40 μm) were used from one section (the left or right hemispheres) to systematically select the region of interest (ROI) randomly superimposed on the iSVZ and oSVZ of both the lookup and reference images at the same positions perpendicular to the ventricular surface. Thymidine analog-labeled or immunostained cells were counted within the ROIs using the “forbidden line” rule [42]. Their densities were calculated using the following formula: [Cell density = Qn−/(a × b × t)] (Qn− = total number of thymidine analogue-labeled and/or immunostained cells appearing within ROIs in the lookup images, but not in the reference images; a = 24, total number of ROIs in the lookup images from two sections (the left and right hemispheres) per animal; b = 40 × 40 μm, areas of counting box; and t = 4 μm, distance between the lookup and reference images).
The percentages of immunostained cells and EdU- and/or BrdU-labeled cells were estimated by summing the cells counted within all ROIs from all animals of each group.

4.4. Statistical Analysis

Measurements from the left and right hemispheres were combined and the number of animals (n) was set to “3” in each group. The density of immunostained cells and EdU- and/or BrdU-labeled cells were statistically analyzed by two-way repeated-measures ANOVA with the region (iSVZ and oSVZ) and group (VPA-exposed and control groups) as factors. For post hoc testing, Scheffe’s test was applied to detect significant differences in the group and/or region × group interactions using two-way repeated-measures ANOVA and simple main effects.
The percentage of cells immunolabeled for the markers among thymidine analogue-labeled cells was statistically assessed using the χ2 test. The total number of EdU single-, BrdU single-, and EdU/BrdU double-labeled cells was defined as “n” for the χ2 test.

5. Conclusions

VPA mediates neurogenesis [11,20,21,22,23,34,35]. It alters the cell-cycle exit of SVZ progenitors (largely the intermediate progenitor cells) during the early stage of cortical neurogenesis in mice [11]. Similar results were obtained in this ferret model, but findings on the stage of neurogenesis and the SVZ progenitor type altered by VPA were distinct. Notable findings of this study are that VPA exposure facilitated the proliferation of SVZ progenitors, mainly Pax6-positive bRG, and their differentiation into Cux1-positive upper layer cortical neurons. The bRG are a major source of a massive expansion of the cerebral cortex, particularly in gyrencephalic mammals [43], and bRG-derived neurons were placed densely in multimodal-associated cortical regions [30]. Thus, a ferret model can offer new insights into the pathogenesis of neurodevelopmental disorders affecting cortical neurogenesis caused by epigenetic factors such as VPA, which may not be observed in a mouse model.

Funding

This study was supported by JSPS KAKENHI (grant number: 15K08144).

Institutional Review Board Statement

All procedures were carried out in line with the National Institutes of Health’s (NIH) Guide for the Care and Use of Laboratory Animals and approved by the Institutional Animal Care and Use Committee of Tsukuba International University (Approval no. 25-1). All procedures attempted to minimize the number and suffering of animals used.

Conflicts of Interest

The author declares no conflict of interest.

References

  1. Phiel, C.J.; Zhang, F.; Huang, E.Y.; Guenther, M.G.; Lazar, M.A.; Klein, P.S. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J. Biol. Chem. 2001, 276, 36734–36741. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Miyazaki, K.; Narita, N.; Narita, M. Maternal administration of thalidomide or valproic acid causes abnormal serotonergic neurons in the offspring: Implication for pathogenesis of autism. Int. J. Dev. Neurosci. 2005, 223, 287–297. [Google Scholar] [CrossRef] [PubMed]
  3. Yochum, C.L.; Dowling, P.; Reuhl, K.R.; Wagner, G.C.; Ming, X. VPA-induced apoptosis and behavioral deficits in neonatal mice. Brain Res. 2008, 1203, 126–132. [Google Scholar] [CrossRef] [PubMed]
  4. Hara, Y.; Maeda, Y.; Kataoka, S.; Ago, Y.; Takuma, K.; Matsuda, T. Effect of prenatal valproic acid exposure on cortical morphology in female mice. J. Pharmacol. Sci. 2012, 118, 543–546. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Mychasiuk, R.; Richards, S.; Nakahashi, A.; Kolb, B.; Gibb, R. Effects of rat prenatal exposure to valproic acid on behaviour and neuro-anatomy. Dev. Neurosci. 2012, 34, 268–276. [Google Scholar] [CrossRef]
  6. Favre, M.R.; Barkat, T.R.; Lamendola, D.; Khazen, G.; Markram, H.; Markram, K. General developmental health in the VPA-rat model of autism. Front. Behav. Neurosci. 2013, 7, 88. [Google Scholar] [CrossRef] [Green Version]
  7. Sabers, A.; Bertelsen, F.C.B.; Scheel-Krüger, J.; Nyengaard, J.R.; Møller, A. Long-term valproic acid exposure increases the number of neocortical neurons in the developing rat brain. A possible new animal model of autism. Neurosci. Lett. 2014, 580, 12–16. [Google Scholar] [CrossRef]
  8. Yasue, M.; Nakagami, A.; Nakagaki, K.; Ichinohe, N.; Kawai, N. Inequity aversion is observed in common marmosets but not in marmoset models of autism induced by prenatal exposure to valproic acid. Behav. Brain Res. 2018, 343, 36–40. [Google Scholar] [CrossRef]
  9. Krahe, T.E.; Filgueiras, C.C.; Medina, A.E. Effects of developmental alcohol and valproic acid exposure on play behavior of ferrets. Int. J. Dev. Neurosci. 2016, 52, 75–81. [Google Scholar] [CrossRef] [Green Version]
  10. Wood, A.G.; Chen, J.; Barton, S.; Nadebaum, C.; Anderson, V.A.; Catroppa, C.; Reutens, D.C.; O’Brien, T.J.; Vajda, F. Altered cortical thickness following prenatal sodium valproate exposure. Ann. Clin. Transl. Neurol. 2014, 1, 497–501. [Google Scholar] [CrossRef]
  11. Fujimura, K.; Mitsuhashi, T.; Shibata, S.; Shimozato, S.; Takahashi, T. In utero exposure to valproic acid induces neocortical dysgenesis via dysregulation of neural progenitor cell proliferation/differentiation. J. Neurosci. 2016, 36, 10908–10919. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Hardan, A.Y.; Jou, R.J.; Keshavan, M.S.; Varma, R.; Minshew, N.J. Increased frontal cortical folding in autism: A precliminary MRI study. Psychiatry Res. 2004, 131, 263–268. [Google Scholar] [CrossRef] [PubMed]
  13. Jou, R.J.; Minshew, N.J.; Keshavan, M.S.; Hardan, A.Y. Cortical gyrification in autistic and Asperger disorders: A preliminary magnetic resonance imaging study. J. Child Neurol. 2010, 25, 1462–1467. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Wallace, G.L.; Robustelli, B.; Dankner, N.; Kenworthy, L.; Giedd., J.N.; Martin, A. Increased gyrification, but comparable surface area in adolescents with autism spectrum disorders. Brain 2013, 136, 1956–1967. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Yang, D.Y.; Beam, D.; Pelphrey, K.A.; Abdullahi, S.; Jou, R.J. Cortical morphological markers in children with autism: A structural magnetic resonance imaging study of thickness, area, volume, and gyrification. Mol. Autism 2016, 7, 11. [Google Scholar] [CrossRef] [Green Version]
  16. Sawada, K.; Kamiya, S.; Aoki, I. Neonatal valproic acid exposure produces altered gyrification related to increased parvalbumin-immunopositive neuron density with thickened sulcal floors. PLoS ONE 2021, 16, e0250262. [Google Scholar] [CrossRef]
  17. Ecker, C.; Ronan, L.; Feng, Y.; Daly, E.; Murphy, C.; Ginestet, C.E.; Brammer, M.; Fletcher, P.C.; Bullmore, E.T.; Suckling, J.; et al. Intrinsic gray-matter connectivity of the brain in adults with autism spectrum disorder. Proc. Natl. Acad. Sci. USA 2013, 110, 13222–13227. [Google Scholar] [CrossRef] [Green Version]
  18. Libero, L.E.; DeRamus, T.P.; Deshpande, H.D.; Kana, R.K. Surface-based morphometry of the cortical architecture of autism spectrum disorders: Volume, thickness, area, and gyrification. Neuropsychologia 2014, 62, 1–10. [Google Scholar] [CrossRef]
  19. Libero, L.E.; Schaer, M.; Li, D.D.; Amaral, D.G.; Nordahl, C.W. Longitudinal study of local gyrification index in young boys with autism spectrum disorder. Cereb. Cortex 2019, 29, 2575–2587. [Google Scholar] [CrossRef]
  20. Wang, Z.; Xu, L.; Zhu, X.; Cui, W.; Sun, Y.; Nishijo, H.; Peng, Y.; Li, R. Demethylation of specific Wnt/β-catenin pathway genes and its upregulation in rat brain induced by prenatal valproate exposure. Anat. Rec. 2010, 293, 1947–1953. [Google Scholar] [CrossRef]
  21. Wang, C.Y.; Cheng, C.W.; Wang, W.H.; Chen, P.S.; Tzeng, S.F. Postnatal stress induced by injection with valproate leads to developing emotional disorders along with molecular and cellular changes in the hippocampus and amygdala. Mol. Neurobiol. 2016, 53, 6774–6785. [Google Scholar] [CrossRef] [PubMed]
  22. Sawada, K.; Kamiya, S.; Aoki, I. The proliferation of dentate gyrus progenitors in the ferret hippocampus by neonatal exposure to valproic acid. Front. Neurosci. 2021, 15, 736313. [Google Scholar] [CrossRef] [PubMed]
  23. Hsieh, J.; Nakashima, K.; Kuwabara, T.; Mejia, E.; Gage, F.H. Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc. Natl. Acad. Sci. USA 2004, 101, 16659–16664. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Fietz, S.A.; Kelava, I.; Vogt, J.; Wilsch-Bräuninger, M.; Stenzel, D.; Fish, J.L.; Corbeil, D.; Riehn, A.; Distler, W.; Nitsch, R.; et al. OSVZ progenitors of human and ferret neocortex are epithelial-like and expand by integrin signaling. Nat. Neurosci. 2010, 13, 690–699. [Google Scholar] [CrossRef] [PubMed]
  25. Hansen, D.V.; Lui, J.H.; Parker, P.R.L.; Kriegstein, A.R. Neurogenic radial glia in the outer subventricular zone of human neocortex. Nature 2010, 464, 554–561. [Google Scholar] [CrossRef]
  26. Shitamukai, A.; Konno, D.; Matsuzaki, F. Oblique radial glial divisions in the developing mouse neocortex induce self-renewing progenitors outside the germinal zone that resemble primate outer subventricular zone progenitors. J. Neurosci. 2011, 31, 3683–3695. [Google Scholar] [CrossRef]
  27. Reillo, I.; de Juan Romero, C.; García-Cabezas, M.Á.; Borrell, V. A role for intermediate radial glia in the tangential expansion of the mammalian cerebral cortex. Cereb. Cortex 2011, 21, 1674–1694. [Google Scholar] [CrossRef] [Green Version]
  28. Kelava, I.; Reillo, I.; Murayama, A.Y.; Kalinka, A.T.; Stenzel, D.; Tomancak, P.; Matsuzaki, F.; Lebrand, C.; Sasaki, E.; Schwamborn, J.C.; et al. Abundant occurrence of basal radial glia in the subventricular zone of embryonic neocortex of a lissencephalic primate, the common marmoset Callithrix jacchus. Cereb. Cortex 2012, 22, 469–481. [Google Scholar] [CrossRef] [Green Version]
  29. Martínez-Cerdeño, V.; Cunningham, C.L.; Camacho, J.; Antczak, J.L.; Prakash, A.N.; Cziep, M.E.; Walker, A.I.; Noctor, S.C. Comparative analysis of the subventricular zone in rat, ferret and macaque: Evidence for an outer subventricular zone in rodents. PLoS ONE 2012, 7, e30178. [Google Scholar] [CrossRef] [Green Version]
  30. Sawada, K. Follow-up study of subventricular zone progenitors with multiple rounds of cell division during sulcogyrogenesis in the ferret cerebral cortex. IBRO Rep. 2019, 7, 42–51. [Google Scholar] [CrossRef]
  31. Reillo, I.; Borrell, V. Germinal zones in the developing cerebral cortex of ferret: Ontogeny, cell cycle kinetics, and diversity of progenitors. Cereb. Cortex 2012, 22, 2039–2054. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Leone, D.P.; Srinivasan, K.; Chen, B.; Alcamo, E.; McConnell, S.K. The determination of projection neuron identity in the developing cerebral cortex. Curr. Opin. Neurobiol. 2008, 18, 28–35. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Arlotta, P.; Molyneaux, B.J.; Chen, J.; Inoue, J.; Kominami, R.; Macklis, J.D. Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo. Neuron 2005, 45, 207–221. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Juliandi, B.; Abematsu, M.; Sanosaka, T.; Tsujimura, K.; Smith, A.; Nakashima, K. Induction of superficial cortical layer neurons from mouse embryonic stem cells by valproic acid. Neurosci. Res. 2012, 72, 23–31. [Google Scholar] [CrossRef]
  35. Zhao, H.; Wang, Q.; Yan, T.; Zhang, Y.; Xu, H.J.; Yu, H.P.; Tu, Z.; Guo, X.; Jiang, Y.H.; Li, X.J.; et al. Maternal valproic acid exposure leads to neurogenesis defects and autism-like behaviors in non-human primates. Transl. Psychiatry 2019, 9, 267. [Google Scholar] [CrossRef] [Green Version]
  36. Nikolian, V.C.; Dennahy, I.S.; Higgins, G.A.; Williams, A.M.; Weykamp, M.; Georgoff, P.E.; Eidy, H.; Ghandour, M.H.; Chang, P.; Alam, H.B. Transcriptomic changes following valproic acid treatment promote neurogenesis and minimize secondary brain injury. J. Trauma Acute Care Surg. 2018, 84, 459–465. [Google Scholar] [CrossRef]
  37. Tsai, L.K.; Tsai, M.S.; Ting, C.H.; Li, H. Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice. J. Mol. Med. 2008, 86, 1243–1254. [Google Scholar] [CrossRef]
  38. Song, N.; Boku, S.; Nakagawa, S.; Kato, A.; Toda, H.; Takamura, N.; Omiya, Y.; Kitaichi, Y.; Inoue, T.; Koyama, T. Mood stabilizers commonly restore staurosporine-induced increase of p53 expression and following decrease of Bcl-2 expression in SH-SY5Y cells. Prog. Neuropsychopharmacol. Biol. Psychiatry 2012, 38, 183–189. [Google Scholar] [CrossRef] [Green Version]
  39. Sawada, K.; Horiuchi-Hirose, M.; Saito, S.; Aoki, I. MRI-based morphometric characterizations of sexual dimorphism of the cerebrum of ferrets (Mustela putorius). Neuroimage 2013, 83, 294–306. [Google Scholar] [CrossRef]
  40. Matsumoto, N.; Shinmyo, Y.; Ichikawa, Y.; Kawasaki, H. Gyrification of the cerebral cortex requires FGF signaling in the mammalian brain. Elife 2017, 6, e29285. [Google Scholar] [CrossRef] [Green Version]
  41. Kamiya, S.; Sawada, K. Immunohistochemical characterization of postnatal changes in cerebellar cortical cytoarchitectures in ferrets. Anat. Rec. 2021, 304, 413–424. [Google Scholar] [CrossRef] [PubMed]
  42. Gundersen, H.J.G. Notes on the estimation of the numerical density of arbitrary profiles: The edge effect. J. Microsc. 1977, 111, 219–223. [Google Scholar] [CrossRef]
  43. Lewitus, E.; Kelava, I.; Huttner, W.B. Conical expansion of the outer subventricular zone and the role of neocortical folding in evolution and development. Front. Hum. Neurosci. 2013, 7, 24. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Ijms 23 04882 g001a 550Ijms 23 04882 g001b 550
Figure 1. Sox2 immunofluorescence with EdU and BrdU labeling in the SVZ of the premature cortex of VPA-exposed and control ferrets at PD 7. (a) Low-magnification images of the oSVZ through iSVZ. (b) High-magnification images of the oSVZ and iSVZ. Open arrowheads, Sox2-positive progenitors with EdU/BrdU double labeling.
Figure 1. Sox2 immunofluorescence with EdU and BrdU labeling in the SVZ of the premature cortex of VPA-exposed and control ferrets at PD 7. (a) Low-magnification images of the oSVZ through iSVZ. (b) High-magnification images of the oSVZ and iSVZ. Open arrowheads, Sox2-positive progenitors with EdU/BrdU double labeling.
Ijms 23 04882 g001aIjms 23 04882 g001b
Ijms 23 04882 g002a 550Ijms 23 04882 g002b 550
Figure 2. Pax6 immunofluorescence with EdU and BrdU labeling in the SVZ of the premature cortex of VPA-exposed and control ferrets at PD 7. (a) Low-magnification images of the oSVZ through iSVZ. (b) High-magnification images of the oSVZ and iSVZ. Open arrowheads, Pax6-positive progenitors with EdU/BrdU double labeling.
Figure 2. Pax6 immunofluorescence with EdU and BrdU labeling in the SVZ of the premature cortex of VPA-exposed and control ferrets at PD 7. (a) Low-magnification images of the oSVZ through iSVZ. (b) High-magnification images of the oSVZ and iSVZ. Open arrowheads, Pax6-positive progenitors with EdU/BrdU double labeling.
Ijms 23 04882 g002aIjms 23 04882 g002b
Ijms 23 04882 g003 550
Figure 3. High-magnification images of Olig2 immunofluorescence with EdU and BrdU labeling in the SVZ of the premature cortex of VPA-exposed and control ferrets at PD 7. Open arrowheads, Olig2-positive progenitors with EdU/BrdU double labeling; closed arrowheads, Olig2-positive progenitors with EdU single labeling.
Figure 3. High-magnification images of Olig2 immunofluorescence with EdU and BrdU labeling in the SVZ of the premature cortex of VPA-exposed and control ferrets at PD 7. Open arrowheads, Olig2-positive progenitors with EdU/BrdU double labeling; closed arrowheads, Olig2-positive progenitors with EdU single labeling.
Ijms 23 04882 g003
Ijms 23 04882 g004 550
Figure 4. Immunofluorescence for postmitotic markers with EdU and BrdU labeling in the SVZ of the premature cortex of VPA-exposed and control ferrets at PD 7. (a) High-magnification images of Cux1 immunofluorescence with EdU and BrdU labeling in the oSVZ and iSVZ. Open arrowheads, Cux1-positive immature neurons with EdU/BrdU double labeling. (b) High-magnification images of Ctip2 immunofluorescence with EdU and BrdU labeling in the oSVZ and iSVZ. Open arrowheads, Ctip2-positive immature neurons with EdU/BrdU double labeling.
Figure 4. Immunofluorescence for postmitotic markers with EdU and BrdU labeling in the SVZ of the premature cortex of VPA-exposed and control ferrets at PD 7. (a) High-magnification images of Cux1 immunofluorescence with EdU and BrdU labeling in the oSVZ and iSVZ. Open arrowheads, Cux1-positive immature neurons with EdU/BrdU double labeling. (b) High-magnification images of Ctip2 immunofluorescence with EdU and BrdU labeling in the oSVZ and iSVZ. Open arrowheads, Ctip2-positive immature neurons with EdU/BrdU double labeling.
Ijms 23 04882 g004
Ijms 23 04882 g005 550
Figure 5. Densities of EdU single-, BrdU single-, and EdU/BrdU double-labeled cells in the iSVZ and oSVZ of the premature cortex of postnatal day (PD) 7 ferrets. Data are shown as mean ± standard error of the mean (SEM). Significance is indicated using Scheffe’s test at * p < 0.01, ** p < 0.001; number of ferrets = 3 each.
Figure 5. Densities of EdU single-, BrdU single-, and EdU/BrdU double-labeled cells in the iSVZ and oSVZ of the premature cortex of postnatal day (PD) 7 ferrets. Data are shown as mean ± standard error of the mean (SEM). Significance is indicated using Scheffe’s test at * p < 0.01, ** p < 0.001; number of ferrets = 3 each.
Ijms 23 04882 g005
Table
Table 1. Incidence of immunostained cells for various markers in EdU single-, BrdU single- and EdU/BrdU double-labeled cells in the subventricular zone of the premature cortex.
Table 1. Incidence of immunostained cells for various markers in EdU single-, BrdU single- and EdU/BrdU double-labeled cells in the subventricular zone of the premature cortex.
VPAControl
    EdU+ cells
% of Sox2+7.8%(25/320) **2.5%(8/315)
% of Pax6+24.5%(91/372) *32.0%(88/275)
% of Olig2+6.9%(22/320) ***14.3%(45/315)
% of Cux1+5.8%(25/430) **1.8%(7/369)
% of Ctip2+4.7%(20/430)2.3%(9/396)
    BrdU+ cells
% of Sox2+83.7%(154/184)88.8%(87/98)
% of Pax6+97.6%(201/206) *92.5%(99/107)
% of Olig2+26.1%(48/184)34.7%(34/98)
% of Cux1+34.8%(106/305) *24.4%(41/168)
% of Ctip2+41.6%(127/205)37.5%(63/168)
    EdU+/BrdU+ cells
% of Sox2+86.1%(31/36) *100%(26/26)
% of Pax6+98.5%(66/67) *82.0%(41/50)
% of Olig2+41.7%(15/36)26.9%(7/26)
% of Cux1+31.8%(21/66)16.7%(5/30)
% of Ctip2+30.3%(20/66)23.3%(7/30)
Percentages were calculated by summing each labeled cell counted within all ROIs from the inner and outer subventricular zones in the premature cortex from 3 ferrets. The numbers of labeled cells used to calculate the percentages are shown in parentheses. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control (χ2 test). EdU+, EdU single-labeled; BrdU+, BrdU single-labeled; EdU+/BrdU+, EdU/BrdU double-labeled; Sox2+, Sox2 immunostaining; Pax6+, Pax6 immunostaining; Olig2+, Olig2 immunostaining; Cux1+, Cux1 immunostaining; Ctip2+, Ctip2 immunostaining.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Sawada, K. Neurogenesis of Subventricular Zone Progenitors in the Premature Cortex of Ferrets Facilitated by Neonatal Valproic Acid Exposure. Int. J. Mol. Sci. 2022, 23, 4882. https://doi.org/10.3390/ijms23094882

AMA Style

Sawada K. Neurogenesis of Subventricular Zone Progenitors in the Premature Cortex of Ferrets Facilitated by Neonatal Valproic Acid Exposure. International Journal of Molecular Sciences. 2022; 23(9):4882. https://doi.org/10.3390/ijms23094882

Chicago/Turabian Style

Sawada, Kazuhiko. 2022. "Neurogenesis of Subventricular Zone Progenitors in the Premature Cortex of Ferrets Facilitated by Neonatal Valproic Acid Exposure" International Journal of Molecular Sciences 23, no. 9: 4882. https://doi.org/10.3390/ijms23094882

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop